6.
Zhang C, Yamashita H, Okumura Y, Yagi K, Aikou S, Seto Y
. Signature and Prediction of Perigastric Lymph Node Metastasis in Patients with Gastric Cancer and Total Gastrectomy: Is Total Gastrectomy Always Necessary?. Cancers (Basel). 2022; 14(14).
PMC: 9319199.
DOI: 10.3390/cancers14143409.
View
7.
Dindo D, Demartines N, Clavien P
. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004; 240(2):205-13.
PMC: 1360123.
DOI: 10.1097/01.sla.0000133083.54934.ae.
View
8.
Polkowski W, Geca K, Skorzewska M
. How to measure quality of surgery as a component of multimodality treatment of gastric cancer. Ann Gastroenterol Surg. 2024; 8(5):740-749.
PMC: 11368491.
DOI: 10.1002/ags3.12833.
View
9.
Priego P, Cuadrado M, Ballestero A, Galindo J, Lobo E
. Comparison of Laparoscopic Versus Open Gastrectomy for Treatment of Gastric Cancer: Analysis of a Textbook Outcome. J Laparoendosc Adv Surg Tech A. 2018; 29(4):458-464.
DOI: 10.1089/lap.2018.0489.
View
10.
Al-Batran S, Hofheinz R, Pauligk C, Kopp H, Haag G, Luley K
. Histopathological regression after neoadjuvant docetaxel, oxaliplatin, fluorouracil, and leucovorin versus epirubicin, cisplatin, and fluorouracil or capecitabine in patients with resectable gastric or gastro-oesophageal junction adenocarcinoma.... Lancet Oncol. 2016; 17(12):1697-1708.
DOI: 10.1016/S1470-2045(16)30531-9.
View
11.
Rawicz-Pruszynski K, van Sandick J, Mielko J, Cisel B, Polkowski W
. Current challenges in gastric cancer surgery: European perspective. Surg Oncol. 2018; 27(4):650-656.
DOI: 10.1016/j.suronc.2018.08.004.
View
12.
Sedlak K, Rawicz-Pruszynski K, Mlak R, Geca K, Skorzewska M, Pelc Z
. Union is strength: Textbook outcome with perioperative chemotherapy compliance decreases the risk of death in advanced gastric cancer patients. Eur J Surg Oncol. 2021; 48(2):356-361.
DOI: 10.1016/j.ejso.2021.08.005.
View
13.
Rawicz-Pruszynski K, Endo Y, Tsilimigras D, Munir M, Katayama E, Sedlak K
. Proximal gastric cancer-time for organ-sparing approach?. J Gastrointest Surg. 2024; 28(6):870-876.
DOI: 10.1016/j.gassur.2024.03.017.
View
14.
Smyth E, Verheij M, Allum W, Cunningham D, Cervantes A, Arnold D
. Gastric cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2016; 27(suppl 5):v38-v49.
DOI: 10.1093/annonc/mdw350.
View
15.
Correa P
. Gastric cancer: overview. Gastroenterol Clin North Am. 2013; 42(2):211-7.
PMC: 3995345.
DOI: 10.1016/j.gtc.2013.01.002.
View
16.
Clavien P, Vetter D, Staiger R, Slankamenac K, Mehra T, Graf R
. The Comprehensive Complication Index (CCI®): Added Value and Clinical Perspectives 3 Years "Down the Line". Ann Surg. 2017; 265(6):1045-1050.
DOI: 10.1097/SLA.0000000000002132.
View
17.
Yamashita H, Toyota K, Kunisaki C, Seshimo A, Etoh T, Ogawa R
. Current status of gastrectomy and reconstruction types for patients with proximal gastric cancer in Japan. Asian J Surg. 2022; 46(10):4344-4351.
DOI: 10.1016/j.asjsur.2022.11.069.
View
18.
. Korean Practice Guideline for Gastric Cancer 2018: an Evidence-based, Multi-disciplinary Approach. J Gastric Cancer. 2019; 19(1):1-48.
PMC: 6441770.
DOI: 10.5230/jgc.2019.19.e8.
View
19.
Levy J, Gupta V, Amirazodi E, Allen-Ayodabo C, Jivraj N, Jeong Y
. Gastrectomy case volume and textbook outcome: an analysis of the Population Registry of Esophageal and Stomach Tumours of Ontario (PRESTO). Gastric Cancer. 2019; 23(3):391-402.
DOI: 10.1007/s10120-019-01015-w.
View
20.
Sedlak K, Rawicz-Pruszynski K, Mlak R, Mielko J, Geca K, Polkowski W
. Better Safe than Sorry: Prevention of Esophagojejunostomy Leak by Intraoperative Methylene Blue Test in Advanced Gastric Cancer. J Gastrointest Surg. 2021; 25(9):2401-2403.
PMC: 8484250.
DOI: 10.1007/s11605-021-04921-6.
View